Patents by Inventor Kenneth G. Mandel

Kenneth G. Mandel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lipstatin derivative—soluble fiber tablets
    Patent number: 7393545
    Abstract: The present invention relates to a novel pharmaceutical composition and process for preparing swallowable rapidity disintegrating methylcellulose and lipstatin derivatives together in combination with a suitable diluent and excipients.
    Type: Grant
    Filed: June 24, 2003
    Date of Patent: July 1, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: Bruce P. Daggy, Kenneth G. Mandel
  • Lipstatin derivative - soluble fiber tablets
    Publication number: 20030232077
    Abstract: The present invention relates to a novel pharmaceutical composition and process for preparing swallowable rapidity disintegrating methylcellulose and lipstatin derivatives together in combination with a suitable diluent and excipients.
    Type: Application
    Filed: June 24, 2003
    Publication date: December 18, 2003
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Bruce P. Daggy, Kenneth G. Mandel
  • Lipstatin derivative-soluble fiber tablets
    Patent number: 6607749
    Abstract: The present invention relates to a novel pharmaceutical composition and process for preparing swallowable rapidly disintegrating methylcellulose and lipstatin derivatives together in combination with a suitable diluent and excipients.
    Type: Grant
    Filed: March 6, 2001
    Date of Patent: August 19, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Bruce P. Daggy, Kenneth G. Mandel
  • Effervescent laxatives
    Patent number: 6444198
    Abstract: The present invention is directed to a novel osmotic/effervescent system for the treatment of constipation and fecal impaction in a human or mammal in need thereof.
    Type: Grant
    Filed: February 7, 2002
    Date of Patent: September 3, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Bruce P. Daggy, Kenneth G. Mandel
  • Effervescent laxatives
    Publication number: 20020085990
    Abstract: The present invention is directed to a novel osmotic/effervescent system for the treatment of constipation and fecal impaction in a human or mammal in need thereof.
    Type: Application
    Filed: February 7, 2002
    Publication date: July 4, 2002
    Applicant: SmithKline Beecham Corporation
    Inventors: Bruce P. Daggy, Kenneth G. Mandel
  • METHOD AND COMPOSITION FOR INCREASING CALCIUM UPTAKE
    Publication number: 20020009474
    Abstract: This invention relates to a hydrophilic matrix containing a pharmaceutically acceptable calcium source for use as a calcium supplement for mammals.
    Type: Application
    Filed: April 6, 1999
    Publication date: January 24, 2002
    Inventors: PRASAD S. ADUSUMILLI, KENNETH G. MANDEL, HARESH L. MIRCHANDANI
  • Picosulfate dosage form
    Patent number: 5631022
    Abstract: A pharmaceutical laxative composition in unit dosage form, for peroral administration of picosulphate to a human or other animal subject, comprising a safe and effective amount of picosulphate in a rapidly dissolving matrix; and a proximal colonic delivery carrier which effects release of said picosulphate substantially near the junction between the small intestine and the colon or within the colon of said subject. This invention also involves methods for providing laxation for humans and other animals in need thereof by peroral administration of such compositions.
    Type: Grant
    Filed: July 6, 1995
    Date of Patent: May 20, 1997
    Assignee: The Procter & Gamble Company
    Inventors: Kenneth G. Mandel, Paula D. Davis
  • Senna dosage form
    Patent number: 5514663
    Abstract: This invention relates to a pharmaceutical laxative composition in unit dosage form, for peroral administration of sennosides to a human or other animal subject, comprising a safe and effective amount of sennosides in a rapidly dissolving matrix; and a proximal colonic delivery carrier which effects release of said sennosides substantially near the junction between the small intestine and the colon or within the colon of said subject. This invention also involves methods for providing laxation for humans and other animals in need thereof by peroral administration of such compositions.
    Type: Grant
    Filed: October 19, 1993
    Date of Patent: May 7, 1996
    Assignee: The Procter & Gamble Company
    Inventor: Kenneth G. Mandel